The Report Guru

The global blood gas analyzer market was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021. Blood gas analyzers are used in conditions such as diabetes, blood vessel hemorrhage, drug overdose and shock for testing several parameters including oxygen concentration, hydrogen ion, electrolytes and partial pressure of carbon dioxide and oxygen. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 Owing to the increasing demand for point of care and automated blood gas analyzers, this market is expected to witness decent growth in the coming years. An increase in number of patients being treated in ICUs, NICUs and emergency departments would further accelerate the pace of growth of blood gas analyzers market. The blood gas analyzer market is segmented on the basis of major product brands (i-STAT, epoc, GEM 3000, GEM 3500, GEM 4000, ABL800, ABL80, ABL90, cobas ...

According to the new market research Blood Gas Analyzer Market is expected to reach USD 636.0 Million by 2021, at a CAGR of 4.6% during the forecast period of 2016 to 2021. A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of this market in the coming years. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 Leading players in blood gas analyzer market are focusing on the launch of new and improved products as their key growth strategy. The major players in the global blood gas analyzer market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany). The top 3 companies’ together...